基本信息
浏览量:313
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
The Institute of Experimental Hematology investigates the biology of blood cell formation and function with a special focus on genetic cell modification as a new therapeutic modality.
Our research groups collaborate to form a portfolio ranging from the generation and expansion of stem cells to the control or enhancement of cell differentiation and function. We connect basic research and strong translational efforts in the field of molecular cell modification for the treatment of severe blood diseases, such as immune disorders and leukemia. The detection and prevention of risks associated with genetic cell modification and training of young scientists are important missions of our Institute.
The Institute of Experimental Hematology contributes to strong research networks of Hannover Medical School, including the DFG-funded cluster of excellence REBIRTH, the collaborative research center SFB738, and the Integrated Research and Treatment Center for Transplantation Medicine (IFB-Tx). Furthermore, we participate in the DFG-funded research priority program “mechanisms of gene vector entry and persistence” (SPP1230), several network projects supported by the BMBF, DAAD and Federal State of Lower Saxony (R2N) as well as integrated projects of the EU Horizon 2020 RECOMB and the ERC.
Our research groups collaborate to form a portfolio ranging from the generation and expansion of stem cells to the control or enhancement of cell differentiation and function. We connect basic research and strong translational efforts in the field of molecular cell modification for the treatment of severe blood diseases, such as immune disorders and leukemia. The detection and prevention of risks associated with genetic cell modification and training of young scientists are important missions of our Institute.
The Institute of Experimental Hematology contributes to strong research networks of Hannover Medical School, including the DFG-funded cluster of excellence REBIRTH, the collaborative research center SFB738, and the Integrated Research and Treatment Center for Transplantation Medicine (IFB-Tx). Furthermore, we participate in the DFG-funded research priority program “mechanisms of gene vector entry and persistence” (SPP1230), several network projects supported by the BMBF, DAAD and Federal State of Lower Saxony (R2N) as well as integrated projects of the EU Horizon 2020 RECOMB and the ERC.
研究兴趣
论文共 685 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jiangshan Xu,Pengcheng Guo, Shijie Hao,Shuncheng Shangguan, Quan Shi,Giacomo Volpe, Keke Huang,Jing Zuo, Juan An, Yue Yuan,Mengnan Cheng, Qiuting Deng,
NATURE GENETICSno. 5 (2024): 953-969
MBIOno. 2 (2024): e0330823-e0330823
MOLECULAR THERAPY NUCLEIC ACIDSno. 1 (2024): 102157-102157
Journal of virologyno. 4 (2024): e0013524-e0013524
Lena Fischer-Riepe,Sareetha Kailayangiri,Katharina Zimmermann,Rita Pfeifer,Michael Aigner,Bianca Altvater,Sascha Kretschmann,Simon Voelkl,Jordan Hartley, Celine Dreger, Katja Petry,Andreas Bosio,
Cancer Researchno. 6_Supplement (2024): 6328-6328
JOURNAL OF MOLECULAR MEDICINE-JMMno. 1 (2024): 143-145
Jan C Klapwijk, Alberto Del Rio Espinola,Silvana Libertini, Philippe Collin, Mick D Fellows,Susan Jobling, Antohny M Lynch,HansJoerg Martus, Catherine Vickers,Andreas Zeller, Luca Biasco, Martijn H Brugman,
Human gene therapy (2024)
Niklas Beschorner, Paul Kuenzle,Maike Voges,Ilona Hauber,Daniela Indenbirken, Jacqueline Nakel, Sanamjeet Virdi,Peter Bradtke,Niels Christian Lory,Michael Rothe,Maciej Paszkowski-Rogacz,Frank Buchholz,
PLOS ONEno. 3 (2024): e0298542-e0298542
HARDWAREX (2024): e00509-e00509
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn